Tag: Schizophrenia
FDA Approves New Drug for Schizophrenia, Bipolar Disorder
Vraylar is an atypical antipsychotic taken once a day
Thalamic Dysconnectivity Seen in Those at Risk for Psychosis
Particularly pronounced among individuals who converted to full-blown illness
FDA Approves Rexulti for Schizophrenia, Depression
But shouldn't be prescribed to some older people
ARVO: Genetic Link ID’d for Strabismus and Schizophrenia
Almost half of the genes dysregulated in strabismic medial rectus muscle are schizophrenia biomarkers
FDA Approves First Generic Abilify
For treatment of bipolar disorder or schizophrenia
Exercise May Improve Neurocognition in Schizophrenia
Aerobic activity offers many benefits, but study needs to be duplicated, researcher says
